Cargando…
Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19
No proven remedy is identified for COVID-19 yet. SARS-CoV-2, the viral agent, is recognized by some endosomal and cytosolic receptors following cell entry, entailing innate and adaptive immunity stimulation, notably through interferon induction. Impairment in immunity activation in some patients, mo...
Autores principales: | Mosaddeghi, Pouria, Shahabinezhad, Farbod, Dorvash, Mohammadreza, Goodarzi, Mojtaba, Negahdaripour, Manica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678415/ https://www.ncbi.nlm.nih.gov/pubmed/33185497 http://dx.doi.org/10.1080/21645515.2020.1833577 |
Ejemplares similares
-
Interferon-inducer antivirals: Potential candidates to combat COVID-19
por: Bagheri, Ashkan, et al.
Publicado: (2021) -
Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021) -
A systems pharmacology approach to identify the autophagy-inducing effects of Traditional Persian medicinal plants
por: Mosaddeghi, Pouria, et al.
Publicado: (2021) -
Author Correction: A systems pharmacology approach to identify the autophagy‑inducing effects of Traditional Persian medicinal plants
por: Mosaddeghi, Pouria, et al.
Publicado: (2021) -
Aging: A cell source limiting factor in tissue engineering
por: Khorraminejad-Shirazi, Mohammadhossein, et al.
Publicado: (2019)